NanoH2O partnership AMI has recent recognition as NanoH2O Partner of the Year and a NanoH2O partner status, indicating strong alignment with leading membrane technology suppliers and potential joint opportunities in advanced desalination and membrane solutions.

Pharma wastewater Recent NX Filtration partnership for pharmaceutical wastewater reuse in the U.S. suggests AMI’s capability and interest in highly regulated, water-intensive industries; pursue cross-sell of advanced treatment systems for pharma and biotech facilities.

Scale and customization With experience from residential to millions of GPD and in-house vertical integration from design to fabrication, AMI can tailor scalable solutions for municipal, commercial, and industrial clients seeking customized water treatment and reuse systems.

Comprehensive service End-to-end offering including feed water analysis, pilot testing, full-scale design and startup, plus a robust in-house QA/QC process and spare parts inventory, enabling faster project timelines and reduced risk for buyers.

High value market fit Revenue size indicates mid-market to upper-mid-market positioning with potential expansion into pharmaceutical, ultrapure water, and municipal sectors; target accounts with needs for reliable membrane-based treatment and long-term service partnerships.